Kun Chen

Dr. Kun Chen

department of Orthopaedic, University of California, Davis, Davis, California, USA
orcid
Skeletal stem cells • Aging • Regeneration • Bone metabolism

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
XJXingzhi Jing
Xingzhi Jing
TDTing Du
Ting Du
Kun ChenKun Chen
Kun Chen
JGJiachao Guo
Jiachao Guo
WXWei Xiang
Wei Xiang
FGFengjing Guo
Fengjing Guo

10 July 2024 in Nature
Verified
Journal Article
Open access
PDF file
MBMuriel E. Babey
Muriel E. Babey
WKWilliam C. Krause
William C. Krause
Kun ChenKun Chen
Kun Chen
CHCandice B. Herber
Candice B. Herber
ZTZsofia Torok
Zsofia Torok
HIHolly A. Ingraham
Holly A. Ingraham
In lactating mothers, the high calcium (Ca2+) demand for milk production triggers significant bone loss1. Although oestrogen normally counteracts excessive bone resorption by promoting bone formation, this sex steroid drops precipitously during this postpartum period. Here we report that brain-derived cellular communication network factor 3 (CCN3) secreted from KISS1 neurons of the arcuate nucleus (ARCKISS1) fills this void and functions as a potent osteoanabolic factor to build bone in lactating females. We began by showing that our previously reported female-specific, dense bone phenotype2 originates from a humoral factor that promotes bone mass and acts on skeletal stem cells to increase their frequency and osteochondrogenic potential. This circulatory factor was then identified as CCN3, a brain-derived hormone from ARCKISS1 neurons that is able to stimulate mouse and human skeletal stem cell activity, increase bone remodelling and accelerate fracture repair in young and old mice of both sexes. The role of CCN3 in normal female physiology was revealed after detecting a burst of CCN3 expression in ARCKISS1 neurons coincident with lactation. After reducing CCN3 in ARCKISS1 neurons, lactating mothers lost bone and failed to sustain their progeny when challenged with a low-calcium diet. Our findings establish CCN3 as a potentially new therapeutic osteoanabolic hormone for both sexes and define a new maternal brain hormone for ensuring species survival in mammals.

27 November 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
SLShuang Liang
Shuang Liang
ZLZheng-Tao Lv
Zheng-Tao Lv
JIAMING ZHANGJIAMING ZHANG
JIAMING ZHANG
YWYu-Ting Wang
Yu-Ting Wang
YDYong-Hui Dong
Yong-Hui Dong
ACAn-min Chen
An-min Chen
Necrostatin-1 (Nec-1) is a specific small molecule inhibitor of receptor-interacting protein kinase 1 (RIPK1) that specifically inhibits phosphorylation of RIPK1. RIPK1 regulates inflammation and cell death by interacting with receptor-interacting serine/threonine protein kinases 3(RIPK3). We hypothesized that Nec-1 may have anti-inflammatory efficacy in patients with osteoarthritis (OA), as the pathophysiology of OA involves the activation of inflammation-related signaling pathways and apoptosis. In this study, we explored the effects of Nec-1 on interleukin (IL)-1β-induced inflammation in mouse chondrocytes and the destabilised medial meniscus (DMM) mouse model. Inhibiting RIPK1 with Nec-1 dramatically suppressed catabolism both in vivo and in vitro, but did not inhibit changes in subchondral bone. Nec-1 abolished the in vitro increases in matrix metalloproteinase (MMP) and ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTs5) expression induced by IL-1β. However, adding high-mobility group box 1 (HMGB1) partially abrogated this effect, indicating the essential role of HMGB1 and Nec-1 in the protection of primary chondrocytes. Furthermore, Nec-1 decreased the expression of Toll-like receptor 4 (TLR4) and stromal cell-derived factor-1 (SDF-1), and attenuated the interaction between TLR4 and HMGB1. Western blot results suggested that Nec-1 significantly suppressed IL-1β-induced NF-κB transcriptional activity, but not MAPK pathway. Micro-computed tomography, immunohistochemical staining, and Safranin O/Fast Green staining were used in vivo to assess the degree of destruction of OA cartilage. The results show that NEC-1 can significantly reduce the degree of destruction of OA cartilage. Therefore, Nec-1 may be a novel therapeutic candidate to treat OA.

7 May 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
Kun ChenKun Chen
Kun Chen
JHJun Hu
Jun Hu
YDYijun Dong
Yijun Dong
MZMenglong Zheng
Menglong Zheng
WZWenzhi Zhang
Wenzhi Zhang
Intervertebral disc degeneration (IDD) is a highly prevalent musculoskeletal disorder affecting millions of adults worldwide, but a poor understanding of its pathogenesis has limited the effectiveness of therapy. In the current study, we integrated untargeted LC/MS metabolomics and magnetic resonance spectroscopy data to investigate metabolic profile alterations during IDD. Combined with validation via a large-cohort analysis, we found excessive lipid droplet accumulation in the nucleus pulposus cells of advanced-stage IDD samples. We also found abnormal palmitic acid (PA) accumulation in IDD nucleus pulposus cells, and PA exposure resulted in lipid droplet accumulation and cell senescence in an endoplasmic reticulum stress-dependent manner. Complementary transcriptome and proteome profiles enabled us to identify solute carrier transporter (SLC) 43A3 involvement in the regulation of the intracellular PA level. SLC43A3 was expressed at low levels and negatively correlated with intracellular lipid content in IDD nucleus pulposus cells. Overexpression of SLC43A3 significantly alleviated PA-induced endoplasmic reticulum stress, lipid droplet accumulation and cell senescence by inhibiting PA uptake. This work provides novel integration analysis-based insight into the metabolic profile alterations in IDD and further reveals new therapeutic targets for IDD treatment.

1 October 2015 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SHShunze Hu
Shunze Hu
HWHuan Wang
Huan Wang
Kun ChenKun Chen
Kun Chen
PCPeng Cheng
Peng Cheng
SGShutao Gao
Shutao Gao
XSXuying Sun
Xuying Sun
MicroRNAs (miRNAs) are small (∼22-nucleotide [nt]) noncoding RNAs that regulate biological processes at the post-transcriptional level. Dysregulation of specific miRNAs leads to impaired synaptic plasticity resulting in Alzheimer’s disease (AD). Amyl

25 June 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Kun ChenKun Chen
Kun Chen
PNPei Ying Ng
Pei Ying Ng
RCRuiying Chen
Ruiying Chen
DHDorothy Hu
Dorothy Hu
SBShawn Berry
Shawn Berry
FGFrancesca Gori
Francesca Gori
Loss-of-function mutations in the Wnt inhibitor secreted frizzled receptor protein 4 (SFRP4) cause Pyle’s disease (OMIM 265900), a rare skeletal disorder characterized by wide metaphyses, significant thinning of cortical bone, and fragility fractures. In mice, we have shown that the cortical thinning seen in the absence of Sfrp4 is associated with decreased periosteal and endosteal bone formation and increased endocortical resorption. While the increase in Rankl/Opg in cortical bone of mice lacking Sfrp4 suggests an osteoblast-dependent effect on endocortical osteoclast (OC) activity, whether Sfrp4 can cell-autonomously affect OCs is not known. We found that Sfrp4 is expressed during bone marrow macrophage OC differentiation and that Sfrp4 significantly suppresses the ability of early and late OC precursors to respond to Rankl-induced OC differentiation. Sfrp4 deletion in OCs resulted in activation of canonical Wnt/β-catenin and noncanonical Wnt/Ror2/Jnk signaling cascades. However, while inhibition of canonical Wnt/β-catenin signaling did not alter the effect of Sfrp4 on OCgenesis, blocking the noncanonical Wnt/Ror2/Jnk cascade markedly suppressed its regulation of OC differentiation in vitro. Importantly, we report that deletion of Ror2 exclusively in OCs (CtskCreRor2fl/fl) in Sfrp4 null mice significantly reversed the increased number of endosteal OCs seen in these mice and reduced their cortical thinning. Altogether, these data show autocrine and paracrine effects of Sfrp4 in regulating OCgenesis and demonstrate that the increase in endosteal OCs seen in Sfrp4−/− mice is a consequence of noncanonical Wnt/Ror2/Jnk signaling activation in OCs overriding the negative effect that activation of canonical Wnt/β-catenin signaling has on OCgenesis. Significance Cortical bone homeostasis combines periosteal bone formation and endocortical remodeling. Flaws in these processes lead to altered cortical bone mass. Yet, little is known about the regulatory specificities of the endocortical vs. the periosteal surfaces, both critical in determining cortical thickness. We have shown that Pyle’s disease is due to loss-of-function mutations in the Wnt antagonist SFRP4 and that its deletion in mice causes skeletal deformities closely mimicking those seen in Pyle’s disease: cortical bone thinning. Here, we further elucidate the mechanism by which cortical bone is affected and report that both osteoblast- and osteoclast-expressed Sfrp4 regulate osteoclastogenesis and that Sfrp4-dependent suppression of the noncanonical Wnt/Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endocortical resorption.